New dementia tool predicts when symptoms will start: ‘Would you want to know?’
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
China Medical System （00867）Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer’s Type
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Study suggests cognitive testing could improve Lewy body dementia diagnosis
Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...
Why Alzheimer’s scientists are rethinking the amyloid hypothesis
Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...
Benzinga (Video) on MSN21h
Cognition Therapeutics Is Targeting A Critical Form Of Dementia
Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...
BioSpace5dOpinion
Opinion: The Cocktail Recipe That Will Cure Alzheimer’s
Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...
Florey Dementia Index: This online tool predicts age of onset for early Alzheimer’s disease
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
Common drug backed by celebs and taken by millions could raise Alzheimer's risk, British researchers discover
Use of the treatment has soared in popularity in recent years now taken by 2.6million women in England according to the ...
조선일보8d
Dementia driver's license loophole sparks safety concerns in South Korea
Dementia drivers license loophole sparks safety concerns in South Korea Koreas lack of legal measures puts dementia patients ...
First pill to slow down Alzheimer’s considered for use on NHS
The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...
Miracle Alzheimer's drug which could slow down the disease is being considered for use on the NHS - giving hope to millions of people
Officials are assessing whether hydromethylthionine mesylate (HMTM) shows sufficient promise to be given the green light for ...